Author

Lisa Thomrongsith

OpenAlex ID: A5078378317

A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.

2018 · Robert F. Cornell, Frederick Lundry Locke, et al. · Journal of Clinical Oncology · 11

A phase 1 multicenter study evaluating the safety and efficacy of MHC class II-restricted MAGE-A3/A6 T-cell receptor engineered T cells (KITE-718) in patients with advanced cancers.

2018 · Partow Kebriaei, Christopher Austin Klebanoff, et al. · Journal of Clinical Oncology · 1

Works count: 2

Citation count: 12

H-index: 1

I10-index: 1